SCHEMBL70279

SCHEMBL70279

COC(=O)c1ccnc(-c2cc(C(=O)OC)ccn2)c1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.86
KDM6B O15054 3/20 0.86
KDM5C P41229 3/20 0.86
KDM4C Q9H3R0 3/20 0.86
KDM2A Q9Y2K7 3/20 0.86
KDM3A Q9Y4C1 3/20 0.86
JMJD6 Q6NYC1 8/20 0.73
KDM5B Q9UGL1 1/20 0.61
ALOX15 P16050 2/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MAOB P27338 1/20 0.54
NPC1 O15118 1/20 0.54
HPGD P15428 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
TSHR P16473 1/20 0.52
ALDH1A1 P00352 1/20 0.52
HTT P42858 1/20 0.51
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29894587 1.00 KDM4E (0.86) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL6514670 0.98 KDM4E (0.83) KDM4EKDM6BKDM5CKDM4CKDM2A
Hydrochloric Acid SCHEMBL6504834 0.98 KDM4E (0.83) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL714108 0.93 KDM4E (0.76) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL2868531 0.93 KDM5C (1.00) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL30774379 0.93 KDM4E (0.76) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL19229659 0.93 KDM4E (0.76) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL29670732 0.93 KDM5C (1.00) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL14944871 0.91 KDM4E (0.73) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL7033789 0.90 KDM4E (0.71) KDM4EKDM6BKDM5CKDM4CKDM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12628491-B2 Organic-inorganic adhesion layer and its use in perovskite solar cells and modules Tandem PV (US) 2026-05-12 US claimed
US-20240121970-A1 ORGANIC-INORGANIC ADHESION LAYER AND ITS USE IN PEROVSKITE SOLAR CELLS AND MODULES Tandem PV 2024-04-11 US claimed
US-8993470-B2 Catalysts for the alkyne metathesis STUDIENGESELLSCHAFT KOHLE MBH (DE) 2015-03-31 US claimed
EP-2556078-B1 CATALYSTS FOR ALKYNE METATHESIS STUDIENGESELLSCHAFT KOHLE MBH (DE) 2014-09-24 EP claimed
US-20130144102-A1 CATALYSTS FOR THE ALKYNE METATHESIS STUDIENGESELLSCHAFT KOHLE MBH (DE) 2013-06-06 US claimed
US-12628491-B2 Organic-inorganic adhesion layer and its use in perovskite solar cells and modules Tandem PV (US) 2026-05-12 US disclosed
US-12612415-B2 Stereoselective process for preparing substituted polycyclic pyridone SHIONOGI & CO., LTD. (JP) 2026-04-28 US disclosed
EP-3693373-B1 STEREOSELECTIVE PROCESS FOR PREPARING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES SHIONOGI & CO (JP) 2025-11-26 EP disclosed
EP-4484463-A1 POLYMERIZABLE COMPOSITION OF CYCLIC OLEFINIC MONOMERS AND ASSOCIATED RING-OPENING METATHESIS POLYMERIZATION PROCESS Telene SAS (FR) 2025-01-01 EP disclosed
US-20240424614-A1 METAL PASTE FOR BONDING, AND BONDED BODY AND METHOD FOR PRODUCING SAME RESONAC CORPORATION (JP) 2024-12-26 US disclosed
EP-4368316-A1 METAL PASTE FOR BONDING, AND BONDED BODY AND METHOD FOR PRODUCING SAME Resonac Corporation (JP) 2024-05-15 EP disclosed
US-20240121970-A1 ORGANIC-INORGANIC ADHESION LAYER AND ITS USE IN PEROVSKITE SOLAR CELLS AND MODULES Tandem PV 2024-04-11 US disclosed
EP-0658564-A1 Electroluminescent compounds and intermediates in their synthesis IGEN, INC. (US) 1995-06-21 EP disclosed
EP-0647849-A2 Detecting the presence of analytes in a sample IGEN, INC. (US) 1995-04-12 EP disclosed
EP-0265519-A4 ELECTROCHEMILUMINESCENT ASSAYS. IGEN INC (US) 1990-05-14 EP disclosed
EP-0339086-A4 ELECTROCHEMILUMINESCENT RHENIUM MOIETIES AND METHODS. IGEN INC (US) 1990-02-20 EP disclosed
EP-0339086-A1 ELECTROCHEMILUMINESCENT RHENIUM MOIETIES AND METHODS IGEN, INC. (US) 1989-11-02 EP disclosed
WO-1989004302-A1 ELECTROCHEMILUMINESCENT RHENIUM MOIETIES AND METHODS IGEN, INC. (US) 1989-05-18 WO disclosed
EP-0265519-A1 ELECTROCHEMILUMINESCENT ASSAYS. IGEN INC (US) 1988-05-04 EP disclosed
WO-1987006706-A1 ELECTROCHEMILUMINESCENT ASSAYS IGEN, INC. (US) 1987-11-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130144102-A1 CATALYSTS FOR THE ALKYNE METATHESIS MSH6, AP3M1, PMS2 KDM4E 4138/4885KDM6B 2028/4885KDM5C 3484/4885
US-12612415-B2 Stereoselective process for preparing substituted polycyclic pyridone POLR1A, RNASEH1, RNASEL KDM4E 2122/4885KDM6B 1269/4885KDM5C 1564/4885
US-12628491-B2 Organic-inorganic adhesion layer and its use in perovskite solar cells and modules EPCAM, CDH1, L1CAM KDM4E 739/4885KDM6B 701/4885KDM5C 1896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.